Effect of angiotensin II receptor blocker on insulin signaling in skeletal muscle cells

Masanobu Kaihara, Yoshio Nakamura, Hirofumi Makino

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Impairment of insulin-dependent glucose uptake in skeletal muscles plays a major role in the pathogenesis of diabetes mellitus. Angiotensin converting-enzyme inhibitor (ACEI) has been demonstrated to improve insulin-sensitivity in diabetic patients, partly through the increase in peripheral blood flow mediated by either suppressed angiotensin II or elevated bradykinin. Recently, angiotensin II type-1 receptor blocker (ARB) has been shown to produce similar effects, postulating the importance of intracellular signaling cross-talk between angiotensin II and insulin. In this brief review, we focused on insulin receptor substrate-1(IRS-1) in skeletal muscle cells, and the significance of its serine(612)-phosphorylation was discussed.

Original languageEnglish
Pages (from-to)1945-1948
Number of pages4
JournalNippon rinsho. Japanese journal of clinical medicine
Volume60
Issue number10
Publication statusPublished - Jan 1 2002

Fingerprint

Angiotensin Receptor Antagonists
Angiotensin II
Muscle Cells
Skeletal Muscle
Insulin
Angiotensin II Type 1 Receptor Blockers
Insulin Receptor Substrate Proteins
Bradykinin
Angiotensin-Converting Enzyme Inhibitors
Serine
Insulin Resistance
Diabetes Mellitus
Phosphorylation
Glucose

Cite this

Effect of angiotensin II receptor blocker on insulin signaling in skeletal muscle cells. / Kaihara, Masanobu; Nakamura, Yoshio; Makino, Hirofumi.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 60, No. 10, 01.01.2002, p. 1945-1948.

Research output: Contribution to journalReview article

@article{b504ab47fb8443c4bedfe46167677797,
title = "Effect of angiotensin II receptor blocker on insulin signaling in skeletal muscle cells",
abstract = "Impairment of insulin-dependent glucose uptake in skeletal muscles plays a major role in the pathogenesis of diabetes mellitus. Angiotensin converting-enzyme inhibitor (ACEI) has been demonstrated to improve insulin-sensitivity in diabetic patients, partly through the increase in peripheral blood flow mediated by either suppressed angiotensin II or elevated bradykinin. Recently, angiotensin II type-1 receptor blocker (ARB) has been shown to produce similar effects, postulating the importance of intracellular signaling cross-talk between angiotensin II and insulin. In this brief review, we focused on insulin receptor substrate-1(IRS-1) in skeletal muscle cells, and the significance of its serine(612)-phosphorylation was discussed.",
author = "Masanobu Kaihara and Yoshio Nakamura and Hirofumi Makino",
year = "2002",
month = "1",
day = "1",
language = "English",
volume = "60",
pages = "1945--1948",
journal = "Nippon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "10",

}

TY - JOUR

T1 - Effect of angiotensin II receptor blocker on insulin signaling in skeletal muscle cells

AU - Kaihara, Masanobu

AU - Nakamura, Yoshio

AU - Makino, Hirofumi

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Impairment of insulin-dependent glucose uptake in skeletal muscles plays a major role in the pathogenesis of diabetes mellitus. Angiotensin converting-enzyme inhibitor (ACEI) has been demonstrated to improve insulin-sensitivity in diabetic patients, partly through the increase in peripheral blood flow mediated by either suppressed angiotensin II or elevated bradykinin. Recently, angiotensin II type-1 receptor blocker (ARB) has been shown to produce similar effects, postulating the importance of intracellular signaling cross-talk between angiotensin II and insulin. In this brief review, we focused on insulin receptor substrate-1(IRS-1) in skeletal muscle cells, and the significance of its serine(612)-phosphorylation was discussed.

AB - Impairment of insulin-dependent glucose uptake in skeletal muscles plays a major role in the pathogenesis of diabetes mellitus. Angiotensin converting-enzyme inhibitor (ACEI) has been demonstrated to improve insulin-sensitivity in diabetic patients, partly through the increase in peripheral blood flow mediated by either suppressed angiotensin II or elevated bradykinin. Recently, angiotensin II type-1 receptor blocker (ARB) has been shown to produce similar effects, postulating the importance of intracellular signaling cross-talk between angiotensin II and insulin. In this brief review, we focused on insulin receptor substrate-1(IRS-1) in skeletal muscle cells, and the significance of its serine(612)-phosphorylation was discussed.

UR - http://www.scopus.com/inward/record.url?scp=0036776986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036776986&partnerID=8YFLogxK

M3 - Review article

C2 - 12397689

AN - SCOPUS:0036776986

VL - 60

SP - 1945

EP - 1948

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 10

ER -